IGF1R and myelodysplastic syndrome: IGF-IR was also expressed on the surface of erythroid lineage cells (CD34-CD235a+) of MDS patients with a percentage of 15.3%, and there was nearly no expression on the surface of T and B lymphocytes (Fig 1F, 1G and 1H).